Work

Pharmacokinetics of the Monoclonal Antibody, Sotrovimab, in Healthy Participants Following IM Administration at Different Injection Sites

Year: 2024

Type: article

Study design: Clinical Trial

Source: Clinical Pharmacology & Therapeutics

DOI: 10.1002/cpt.3515

Authors: Asma El‐Zailik, Jennifer Sager, Yasmin Sánchez‐Pearson, Sergio Parra, Jennifer Moore, Prosenjit Sarkar, Alicia Aylott, Qianwen Wang, Melissa Aldinger, Chad Garner, Erik Mogalian, Andrew Skingsley, Amanda Peppercorn, Maribel Reyes

Institutions: VIR Biotechnology (United States), GlaxoSmithKline (United Kingdom), GlaxoSmithKline Research & Development Limited (United Kingdom), GlaxoSmithKline (India), GlaxoSmithKline (United States)

Language: English

Topic: SARS-CoV-2 and COVID-19 Research

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: GlaxoSmithKline Japan, Vir Biotechnology

OpenAlex ID: W4405384730

FWCI: 0.63

Cites: 29

Cited by: 2

Related to: 10